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Abstract
Type 2 diabetes (T2D) hampers recovery after stroke, but the underling mechanisms are mostly unknown. In a recently 
published study (Pintana et al. in Clin Sci (Lond) 133(13):1367–1386, 2019), we showed that impaired recovery in T2D 
was associated with persistent atrophy of parvalbumin+ interneurons in the damaged striatum. In the current work, which 
is an extension of the abovementioned study, we investigated whether somatostatin (SOM)+ interneurons are also affected 
by T2D during the stroke recovery phase. C57Bl/6j mice were fed with high-fat diet or standard diet (SD) for 12 months 
and subjected to 30-min transient middle cerebral artery occlusion (tMCAO). SOM+ cell number/density in the striatum 
was assessed by immunohistochemistry 2 and 6 weeks after tMCAO in peri-infarct and infarct areas. This was possible by 
establishing a computer-based quantification method that compensates the post-stroke tissue deformation and the irregular 
cell distribution. SOM+ interneurons largely survived the stroke as seen at 2 weeks. Remarkably, 6 weeks after stroke, the 
number of SOM+ interneurons increased (vs. contralateral striatum) in SD-fed mice in both peri-infarct and infarct areas. 
However, this increase did not result from neurogenesis. T2D completely abolished this effect specifically in the in the infarct 
area. The results suggest that the up-regulation of SOM expression in the post-stroke phase could be related to neurological 
recovery and T2D could inhibit this process. We also present a new and precise method for cell counting in the stroke-
damaged striatum that allows to reveal accurate, area-related effects of stroke on cell number.
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Introduction
Type 2 Diabetes (T2D), a major risk factor for stroke, dra-
matically hampers neurological recovery in the surviving 
patients (Jorgensen et al. 1994; Baird et al. 2002; Megherbi 
et al. 2003) and is a strong predictor of persistent depend-
ency on assistance in activities of daily living (ADL) 
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(Ullberg et al. 2015). There are several possible mechanisms 
wherein diabetes leads to stroke. These include vascular 
endothelial dysfunction, increased early-age arterial stiff-
ness, systemic inflammation and thickening of the capillary 
basal membrane (Chen et al. 2016).
Impaired neurological recovery in T2D cannot be 
explained by only more severe brain damage after stroke 
(Sweetnam et al. 2012; Tulsulkar et al. 2016; Dhungana 
et al. 2013) and several mechanisms including impaired vas-
cular restoration (Ergul et al. 2015), increased inflammation 
(Dhungana et al. 2013) and impaired stroke-induced neuro-
genesis (Zhang et al. 2016; Pintana et al. 2019) have been 
proposed. Neuroplasticity, i.e. the ability of the nervous sys-
tem to respond to stimuli by reorganizing its structure, func-
tion and connections, is also considered an important mech-
anism involved in post-stroke recovery (Alia et al. 2017; 
Mang et al. 2013) and different types of neurons play key 
roles in this process (Greifzu et al. 2014; Quattromani et al. 
2018; Wieloch and Nikolich 2006). Interestingly, T2D has 
been reported to diminish cortical plasticity (Sweetnam et al. 
2012) in rodents and importantly, in patients (Huynh et al. 
2017). Moreover, we recently showed that impaired stroke 
recovery in T2D may also be associated with increased atro-
phy of striatal GABA-ergic parvalbumin (PV)+ interneurons 
(Pintana et al. 2019), suggesting diminished neuroplasticity 
in striatum.
Apart from PV+ interneurons, other interneurons could be 
involved in stroke recovery and among them, somatostatin+ 
(SOM+) neurons are plausible candidates. SOM is a small 
14 amino-acid-long peptide present in many regions of the 
central and peripheral nervous system (Patel 1999). In the cen-
tral nervous system (CNS), positive correlation between the 
amount of expressed somatostatin and increased performance 
in hippocampus-dependent learning tasks has been observed 
(Liguz-Lecznar et al. 2016; Nilsson et al. 1993). Addition-
ally, SOM+ interneurons were demonstrated to be involved 
in driving neuroplasticity and contributing to the reshaping of 
neural networks in three characterized neuroplasticity models 
(ocular dominance changes, classical fear conditioning and 
experience-dependent barrel cortex plasticity) (Tang et al. 
2014). SOM+ cells largely co-stain with Neuropeptide Y 
(NPY) (Rushlow et al. 1995), a 36-amino acid residue long 
peptide implicated in regulations of important biological and 
pathophysiological functions such as neuroendocrine secre-
tions, feeding behavior, circadian rhythms, seizures, neuronal 
excitability, neuroplasticity, and memory (Gotzsche and Wold-
bye 2016). Interestingly, in models of brain ischemia, there 
is a selective sparing of SOM/NPY expressing interneurons 
in striatum as demonstrated in a gerbil and in a rat model of 
global forebrain ischemia at different time points after stroke 
(4 days and 2–28 days respectively) (Uemura et al. 1990; Lars-
son et al. 2001). Moreover, this selective interneurons sparing 
was confirmed in a more complex animal model of ischemia, 
as showed by Mallard et al. in the brain of sheep fetuses that 
underwent to repeated hypoxia (Mallard et al. 1995). Specifi-
cally, in the striatum the number of these neurons is usually 
reduced shortly after stroke (4 h/1 day) followed by normaliza-
tion to baseline-like values in 3/7 days (Grimaldi et al. 1990), 
likely due to down- and up-regulation of somatostatin expres-
sion. Furthermore, this effect seems to be influenced by the 
stroke-damaged brain area in which SOM/NPY cell number 
is evaluated, resulting in a delay in the cortex (40 days for 
complete recovery) and complete absence in the hippocampus 
(no recovery after stroke) (Grimaldi et al. 1990). This regu-
lation pattern suggests that this interneuron type may play a 
specific role in post-stroke recovery. However, the potential 
role of these cells to affect stroke recovery is undetermined. 
Moreover, whether T2D affects SOM+ interneuron survival 
after stroke has not been previously investigated.
To determine whether SOM+ interneurons are affected 
during the recovery phase after stroke, it is necessary to 
evaluate the density of SOM+ cells in the striatum discrimi-
nating between areas more (infarct area) or less (peri-infarct 
area) affected by the ischemic injury. As these interneurons 
are not uniformly distributed in striatum (Takagi et al. 1983) 
(i.e. they concentrate mainly adjacent to the lateral ventricle, 
which is the area usually less affected in focal stroke mod-
els), simply comparing the number of SOM+ cells between 
contralateral and ipsilateral hemispheres is not precise. 
Moreover, the deformation of tissue after stroke should be 
considered in this kind of quantitative evaluation.
The aim of this study was to determine whether T2D 
affects the survival of striatal SOM+ interneurons in the 
post-stroke recovery phase in the mouse at 2 and 6 weeks 
after stroke. To precisely quantify SOM+ interneurons in 
peri-infarct and infarct areas, we set up a new computer-
ized methodology that takes advantage of the complemen-
tary use of microscopy and an image-editing software. This 
study represents the extension of a previous study carried 
out by our group (Pintana et al. 2019) where we employed 
an experimental design of clinical relevance in which T2D 
was induced by 12 months feeding with high-fat diet (HFD). 
In this setting, we showed that the neurological impairment 
after stroke in HFD-fed mice was similar to healthy, standard 
diet (SD)-fed mice at 2 weeks after tMCAO (Pintana et al. 
2019). However, while SD-fed mice recovered at 6 weeks 
after stroke, neurological function remained significantly 
impaired in HFD-fed mice (Pintana et al. 2019).
Materials and Methods
Animal Models and Experimental Design
All experiments were conducted in accordance with the 
Guidelines for Care and Use of Laboratory Animals 
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published by US National Institute of Health (Eighth edi-
tion 2011) and approved by the regional ethics committee 
(Stockholm Södra Djurförsöketiska Nämnd) for animal 
experimentation (application No S7–13). This study repre-
sents the extension of a previous study (Pintana et al. 2019). 
Therefore, the material from the same mice cohort was used 
to obtain the data showed in this paper. This is in line with 
the guideline principles at our institution, with the aim to 
improve the ethical use of animals in testing according to 
the 3 R principle (Balls 2009).
Briefly, thirty-nine, male 8-week-old C57/BL6j mice 
(Charles River Laboratories, Germany) were used. The mice 
were randomized to two groups: fed with standard labora-
tory diet (SD) (n = 22) or high-fat diet (HFD: 60% energy 
from fat) (n = 17) for 12 months. All mice were housed in 
environmentally controlled conditions (25 ± 0.5 °C, 12/12 h 
light/dark cycle with ad libitum access to food and water). 
T2D and obesity were defined as fasting blood glucose over 
7 mmol/L and weight gain over 15% respectively (the data 
are presented in the Supplementary material of Pintana 
et al. 2019). After 12 months of the diet regimen, mice were 
subjected to experimental stroke (SD, n = 18; HFD, n = 13) 
or sham surgery (SD, n = 4 HFD, n = 4). Then, mice were 
divided into two studies:
Study 1
21 mice subjected to tMCAO (SD, n = 13; HFD, n = 8) plus 
8 shams mice (SD, n = 4 HFD, n = 4) were sacrificed for 
histological assessment after 6 weeks.
Study 2
10 mice subjected to tMCAO (SD, n = 5, HFD, n = 5) were 
killed after 2 weeks for additional histological analysis at 
this earlier time point.
To mark newly born cells, all mice received daily intra-
peritoneal injections of the thymidine analog bromodeox-
yuridine (BrdU; 50 mg/kg of BW) for 2 weeks following 
tMCAO.
The results about metabolic parameters, stroke brain dam-
age and functional recovery after tMCAO have been recently 
published (Pintana et al. 2019) and are summarized in the 
Results section.
Transient Middle Cerebral Artery Occlusion (tMCAO)
tMCAO was used to model stroke. tMCAO was induced by 
intraluminal filament technique (Hara et al. 1996). To induce 
striatal infarct with minimal cortical and hippocampal dam-
age, middle cerebral artery (MCA) was occluded for 30 min. 
Briefly, mice were anesthetized by 3% isoflurane, then main-
tained by 1.5% isoflurane through a snout-mask throughout 
the surgery. Body temperature was maintained at 37–38 °C 
using a heated pad. Through midline incision, left common, 
external and internal carotid arteries were exposed. Through 
an incision in an external carotid artery, a 15 mm long, 7–0 
silicone-coated monofilament (total diameter 0.17–0.18 mm) 
was inserted into the internal carotid artery until it could not 
be advanced any further and at least 8–10 mm of filament 
length has passed the carotid bifurcation thus blocking the 
origin of the MCA. Then, wounds were temporarily closed, 
and mice were allowed to wake up. After 25 min mice were 
re-anesthetized, wound reopened and the occluding filament 
removed (total tMCAO time 30 min). Additionally, the suc-
cess of the stroke-induction was evaluated by scoring the 
severity of neurological deficits 1 h after reperfusion and 
the next day after tMCAO surgery using a 3-point system: 1 
point for circling towards the paretic side, 1 point for right 
forelimb sensory deficit (left hanging from the table edge) 
and 1 point for hind limb sensory deficit. All animals used in 
the study reached a minimum of 2 points (data not shown).
Immunohistochemistry
Brain preparation was performed as described previously 
(Chiazza et al. 2018; Darsalia et al. 2016; Lietzau et al. 
2018, 2020). Mice were deeply anesthetized and transcar-
dially perfused with phosphate-buffered saline (PBS) fol-
lowed by 4% ice-cold paraformaldehyde, then the brains 
were removed and after overnight post-fixation submersed 
in PBS containing 20% sucrose until they sank. The brains 
were cut in 30-μm-thick coronal sections using a sliding 
microtome. Immunofluorescence staining was performed 
using free-floating method. Following primary antibodies 
were used; rabbit anti-somatostatin (SOM) (1:1,500 dilu-
tion; #20067; Immunostar); rat anti-somatostatin (SOM) 
(1:500; #sc-47706; Santa Cruz); rabbit anti-neuropeptide 
Y (NPY) (1:1,000 dilution; #22,940; Immunostar); mouse 
anti dopamine- and cAMP-regulated neuronal phosphopro-
tein-32 (DARPP-32) (1:250 dilution; #sc-271111; Santa 
Cruz); rabbit anti Calretinin (Cr) (1:300 dilution; #VP-
RM11; Vector laboratory); rabbit anti Choline acetyltrans-
ferase (ChAT) (1:200 dilution; #AB143; Millipore) mouse 
anti-NeuN (1:200 dilution; #MAB377; Millipore); goat anti 
Ionized calcium-binding adaptor molecule 1 (Iba-1) (1:1,000 
dilution; #ab5076; Abcam); rat anti-Bromodeoxyuridine 
(BrdU) (1:500 dilution; #ab6326; Abcam); mouse anti-par-
valbumin (PV) (1:1,500 dilution; #P3088; Sigma); rabbit 
anti Oligodendrocyte transcription factor (Olig-2) (1:500 
dilution; #AB9610; Millipore); rabbit anti-Glial fibrillary 
acidic protein (GFAP) (1:2,000 dilution; # Z0334; DAKO); 
rabbit anti-S100beta (1:3000 dilution; # ab41548; Abcam). 
Sections were incubated with primary antibodies overnight 
at 4 °C in a phosphate buffer containing 3% appropriate 
serum and 0.25% Triton X-100. Primary antibodies were 
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detected by Alexa 488-or Alexa 594-conjugated (Vector 
laboratory), Cyanine3-conjugated (Thermo Fisher scien-
tific) or biotin-conjugated (Vector Laboratories, Sweden) 
secondary antibodies (1:200 dilution). Sections were incu-
bated with secondary antibodies for 2 h at room tempera-
ture (approximately 21 °C) in phosphate buffer containing 
3% of the appropriate serum and 0.25% Triton X-100. For 
chromogenic visualization, avidin–biotin complex (ABC kit, 
Vector Laboratories, Sweden) and diaminobenzidine (DAB; 
Sigma-Aldrich, US) were used. For antigen retrieval 1 mM 
EDTA for 30 min at 69 °C was applied for double staining, 
or 1 M HCl for 20 min at 64 °C (for double staining between 
rat anti BrdU and rabbit anti SOM).
Quantitative Microscopy
The Olympus BX51 epi-fluorescent/light microscope 
(Olympus) connected with computerized setup for ste-
reology (NewCast Software, Visiopharm) were used for 
cell counting. All quantifications were performed by an 
investigator blinded to group identities. Two counting 
methods were used and compared.
Method 1 three consecutive brain sections spaced at 
300 μm containing striatum (from Bregma 1 to 0.5 mm) 
were used. The first section was chosen based on an ana-
tomical location along the rostra-caudal axis (approxi-
mately 1 mm from Bregma). The second and the third 
sections were 300 and 600 μm caudal from the first sec-
tion respectively. Immuno-positive cells were counted 
using the NewCast software (VisioPharm, Denmark). 
Briefly, striatum on 3 coronal sections (described above) 
was delineated and the counting frame was systematically 
moved at preset intervals starting from random position, 
so that the representative fraction of the region of interest 
was sampled. The total cell number from three sections 
was estimated using the following formula: Total number 
of immuno-reactive cells = Counted number × (Step area/
Counting frame area) (Chiazza et al. 2018; Pintana et al. 
2019).
Method 2 all positive cells were counted in striatum in 
one section (≈ 0.5 mm from Bregma).
In both counting methods the mean of the contralat-
eral immuno-positive cell number was calculated, and the 
ipsilateral cell number was normalized to the contralateral 
mean. In this way we obtained the mean of contralateral 
cell number set to 100% in both methods, and ipsilateral 
cell number expressed as percentage change compared to 
contralateral. The two counting methods produced iden-
tical results (Fig. S1); therefore, all quantifications were 
performed in a single brain section from each animal by 
using Method 2.
Cell Density Evaluation
To evaluate the differences in SOM+ cells in the infarct and 
peri-infarct areas of the ipsilateral hemisphere, cell density 
per  mm2 was calculated. The density of SOM+ cells was 
calculated by dividing the number of SOM+ cells by the 
area  (mm2) in which these cells were quantified.
For the evaluation of the density of SOM+ cells in the 
ipsilateral hemisphere, the post-stroke deformation of the 
striatum was considered. From our previous studies (Fig. 
S2) there is no deformation at all in the Peri-Infarct area of 
the striatum after stroke, but only in the area where there is 
an infarct. Thus, to extrapolate the “deformation coefficient” 
of the infarct area, this formula was used:
αs is the deformation coefficient, C contralateral striatal area, 
P ipsilateral striatal peri-infarct area, I ipsilateral striatal 
infarct area.
The deformation coefficient was used to correct the den-
sity of SOM+ cells in the ipsilateral infarct area using this 
formula:
δc is the real cell density (corrected), δo is the cell density 
obtained, αs is the deformation coefficient.
This formula was used only to correct the density in ipsi-
lateral infarct area, being that, as already stated, peri-infarct 
area is not affected by the deformation (shrinking in this 
case).
From literature (Takagi et al. 1983) and from data col-
lected for this study, SOM+ cells distribution in striatum is 
not uniform. While this non-uniformity is negligible under 
normal conditions, it gains great importance in the case of 
focal striatal stroke, as striatal SOM+ cells are more con-
centrated in the area adjacent to the lateral ventricle, and 
this area is usually the least affected by the tMCAO. This 
feature was considered in the SOM+ cells density compari-
son of contralateral vs. ipsilateral. Thus, the density of the 
SOM+ cells in the ipsilateral peri-infarct area was compared 
to the density in the anatomically corresponding contralat-
eral area, and not to the SOM+ cells density in the whole 
contralateral striatum. Similarly, the density of the SOM+ 
cells in the Ipsilateral infarct area (corrected as described 
above) was compared to the anatomically corresponding 
contralateral area. To correctly delineate the corresponding 
peri-infarct or infarct area in the contralateral hemisphere, 
an image-editing software was used (Adobe Photoshop CC 
2019). Briefly, a high-resolution image of the brain section 















Cellular and Molecular Neurobiology 
1 3
was superimposed over a high-resolution, image of a similar 
brain section from the same animal stained for NeuN. On 
these two images, was further superimposed a diagram of 
the position of the SOM+ cells from the contralateral and 
ipsilateral striata (Fig. 1a, b). By using this diagram over-
posed to NeuN stained section, SOM+ cells in the ipsilateral 
were identified and divided in peri-infarct and infarct area 
(green and blue dots respectively). Then the diagram of the 
Contralateral SOM+ cells was mirrored and over-imposed 
to the ipsilateral NeuN stained striatum and cells in the cor-
responding peri-infarct area were counted (Fig. 1c). Finally, 
the number of SOM+ cells in the contralateral infarct cor-
responding area was calculated by subtracting the number 
of SOM+ cells in the contralateral peri-infarct correspond-
ing area from the total number of SOM+ cells in the whole 
contralateral.
All procedures were performed by experimenter blinded 
to experimental groups.
Statistical Analysis
The significance of the differences between 2 groups was 
calculated using the unpaired t test with Welch’s correc-
tion. The comparisons between three groups were performed 
using the one-way ANOVA test with Bonferroni multiple 
comparisons. Data are expressed as mean ± SEM. P-value 
less than 0.05 was considered statistically significant. All 
data were analyzed by using GraphPad Prism 7.
Results
Effects of T2D on Metabolic Parameters, Stroke 
Volume and Functional Recovery After tMCAO
As stated above, this study is based on the reuse of the mate-
rial from a previously published project from our group (Pin-
tana et al. 2019). The metabolic results as well as the stroke 
volume and functional recovery data are summarized below. 
Briefly, 12 months of HFD induced an impaired metabolic 
profile, determined by a significant increase in body weight, 
increased fasting glycemia and impaired glucose tolerance 
(Pintana et al. 2019). The ischemic brain damage was mainly 
localized in dorsolateral striatum. No significant differences 
between SD- and HFD-fed mice were detected in stroke vol-
ume or in upper-limb grip strength between SD-fed mice and 
HFD-fed mice before stroke (Pintana et al. 2019). Stroke 
significantly decreased upper-limb grip strength (before 
stroke vs. 1 week) in both SD and HFD-fed mice. However, 
at 6 weeks after stroke, SD-fed mice significantly recovered 
upper-limb grip strength (1 vs. 6 weeks, P < 0.0001), while 
HFD-fed mice did not and remained significantly different 
from before stroke and HFD sham (Pintana et al. 2019).
Fig. 1  Representation of the protocol for a new method for the evalu-
ation of Somatostatin (SOM)+ cell density. A high-resolution image 
of the brain section from each animal (≈  0.5  mm from Bregma) 
stained for SOM was superimposed over a high-resolution, image of 
a similar brain section from the same animal stained for NeuN. On 
these two images, was further superimposed a diagram of the position 
of the SOM+ cells from the contralateral and ipsilateral striata (a, b). 
By using this diagram over-posed to NeuN stained section, SOM+ 
cells in the ipsilateral were identified and divided in peri-infarct and 
infarct area (green and blue dots respectively). Then the diagram of 
the Contralateral SOM+ cells was mirrored and over-imposed to the 
ipsilateral NeuN stained striatum and cells in the corresponding peri-
infarct area were counted (c). Finally, the number of SOM+ cells in 
the contralateral infarct corresponding area was calculated by sub-
tracting the number of SOM+ cells in the contralateral peri-infarct 
corresponding area from the total number of SOM+ cells in the 
whole contralateral
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Stroke Increases SOM+ Interneurons in the Whole 
Striatum 6 Weeks After Stroke; An Effect 
that is Partially Hampered by T2D
Two weeks after stroke, no differences were observed in 
the number of SOM+, NPY+ and SOM+/NPY+ co-stained 
cells in ipsilateral versus contralateral striatum in both ani-
mals fed a SD or an HFD (Fig. 2a–c). These results confirm 
the selective sparing of this interneuron subtype after stroke 
(Grimaldi et al. 1990; Mallard et al. 1995; Larsson et al. 
2001).
Six weeks after stroke, SOM+ cells number was sig-
nificantly increased in ipsilateral striatum of SD-fed mice 
compared to contralateral (P < 0.01, Fig. 2d). This stroke-
dependent effect did not occur in HFD-fed mice (P = 0.35, 
Fig.  2d). Similar results were obtained when assessing 
NPY+ cells or SOM+/NPY+ co-staining cells (Fig. 2e, f).
This increase of SOM+ in SD-fed mice appears to occur 
in the ischemia injured hemisphere, and not because of a 
change of SOM+ cells in contralateral striatum, as no dif-
ferences were detected in cell number between sham brains 
and contralateral hemispheres (Fig. S2).
Overall these results confirm the remarkable resistance 
of SOM+ and NPY+ cells up-to 2  weeks after stroke. 
Importantly, our results show that stroke increased SOM+ 
and NPY+ cell number 6 weeks after stroke in SD mice 
while T2D prevented this stroke-dependent effect.
Type 2 Diabetes Prevents the Stroke‑Induced 
Increase of SOM+ Interneurons in the Infarct Stroke 
Area Without Affecting the Peri‑infarct Area
The quantitative analysis of the whole ipsilateral SOM+ or 
NPY+ cells number was not sufficiently sensitive to reveal 
a statistical difference between ipsilateral SD and ipsilateral 
HFD (Fig. 2d–f). Therefore, to further deepen our investiga-
tion, we set up a new methodological approach to calculate 
cell density at 6 weeks after stroke to separately assess the 
stroke-dependent variation in SOM+ cell number in peri-
infarct and infarct areas (Fig. 3a). We also adjusted our quan-
tifications based on the stroke-induced striatum deformation 
(Fig. 3a and “Materials and Methods” section for further 
details). Due to the similar results in the quantifications of 
SOM+, NPY+ and SOM+/NPY+ interneurons (Fig. 2d–f) 
and considering that almost 100% of the NPY+ cells in 
striatum co-stain with SOM cells (Rushlow et al. 1995), we 
focused the cell density (δc) quantifications solely in SOM+ 
cells (see “Materials and Methods” section).
Fig. 2  Effect of Type 2 diabetes (T2D) on stroke-induced somatosta-
tin (SOM)+ or neuropeptide Y (NPY)+ single staining and SOM+/
NPY+ double staining cell number 2 and 6  weeks after transient 
Middle Cerebral Artery Occlusion (tMCAO). The percentage of the 
SOM+ cell, NPY+ cell and SOM+/NPY+ cell number after normali-
zation for the mean value of respective contralateral at 2  weeks (a, 
b and c) and 6 weeks after stroke (d, e and f), respectively in mice 
fed a standard diet (SD) or a High Fat Diet (HFD). One-way ANOVA 
test with Bonferroni post-test, means ± SEM. *P < 0.05; **P < 0.01; 
***P < 0.001
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The results show that 6 weeks after stroke SD-fed mice 
increased approximately 40% the adjusted SOM+ δc in 
ipsilateral peri-infarct (P < 0.05; Fig.  3b, f) and infarct 
(P < 0.05; Fig. 3c, f) areas if compared to their correspond-
ing contralateral areas. T2D showed a similar pattern in the 
δc of SOM+ interneurons in the peri-infarct area (P < 0.05; 
Fig. 3d, f). However, T2D entirely abolished the increase of 
SOM+ δc in the infarct area (P = 0.6; Fig. 3e, f).
Overall these results indicate a significant effect of T2D 
to block the increase of SOM+ interneurons in the stroke 
infarct area 6 weeks after stroke. This effect could not be 
obtained by quantifying SOM+ cells in the whole striatum, 
and without considering the stroke-induced striatal deforma-
tion effect, thus demonstrating the increased sensibility of 
our newly established quantitative method.
The Increased Number of SOM+ Interneurons 
After Stroke Does Not Result From Neurogenesis 
or Increased SOM Expression in Other Neuronal 
or Glial Cell Populations
To investigate if the increased number of SOM+ interneu-
rons resulted from an up-regulation of this marker in 
SOM− cells, we performed co-staining of SOM with several 
neuronal and glial markers in ipsilateral striatum of mice fed 
a SD 6 weeks after stroke.
We found a 100% overlap between SOM and NeuN 
(Fig. 4a), a ubiquitous marker of mature neurons, confirm-
ing the neuronal nature of SOM+ cells. We further con-
firmed this result as no co-staining was detected between 
SOM and Olig-2 (a marker of the oligodendrocytes line-
age) (Fig. 4b), Iba-1 (a marker of microglia) (Fig. 4c) and 
GFAP or S100 Beta (2 markers of astroglia) (Fig. 4d, e). 
Since, SOM expression was also absent in spiny neurons, 
as assessed by co-staining between SOM and the spiny neu-
ronal marker DARPP-32 (Fig. 4f), we then investigated the 
possibility that after stroke, SOM-negative interneurons had 
acquired SOM expression by performing co-staining with 
SOM and parvalbumin (PV), calretinin (Cr) and Choline 
acetyltransferase (ChAT). The results of these assessments 
were all negative (Fig. 4g–i).
To investigate the potential formation of new-born SOM+ 
interneurons, we treated mice with the thymidine analog 
BrdU for 2 weeks after stroke and assessed the number of 
double positive SOM+/BrdU+ cells 6 weeks thereafter. No 
co-staining was found between SOM and BrdU (Fig. 4j) 
indicating that these are not newborn cells related to stroke-
induced neurogenesis.
Overall the results suggest that stroke increases the 
expression of SOM in interneurons, likely within SOM+ 
cells that weakly express SOM and are undetectable in 
absence of stroke injury.
Discussion
The aim of this project, that is the extension of a previous 
study carried out by our group (Pintana et al. 2019), was 
to determine whether T2D affects the vulnerability of stri-
atal SOM+ interneurons in the post-stroke recovery phase 
in the mouse. We demonstrated that stroke induces an 
increase in the number of SOM+ and NPY+ interneurons 
in the ipsilateral whole striatum of normal mice 6 weeks 
after stroke and that this effect is completely abolished 
by T2D. This T2D-mediated effect occurs specifically in 
the ischemic core but not in the peri-infarct stroke-dam-
aged striatum. To generate these results, we setup a new 
computerized methodology that takes advantage of the 
complementary use of microscopy and an image-editing 
software. This method could reveal useful to also quantify 
other type of cells in striatum after ischemic damage.
SOM+ and NPY+ GABA-ergic interneurons have been 
shown to be involved in brain neuroplasticity (Tang et al. 
2014). Specifically in relation to stroke, several groups 
have shown that after cerebral ischemia, SOM+/NPY+ 
expressing neurons in striatum are selectively spared 
(Uemura et al. 1990; Larsson et al. 2001), with an ini-
tial reduction in the first phases after surgery (4 h–1 day) 
and then return to baseline-like values 3–7 days after 
stroke (Grimaldi et al. 1990; Mallard et al. 1995) sug-
gesting their potential role in post-stroke-related neuronal 
plasticity. Here, we confirm that these interneurons are 
spared in the first weeks after surgery (2 weeks) when 
also similar neurological recovery in SD and HFD-fed 
mice was observed (Pintana et al. 2019). However, we 
reported for the first time, that with longer time after 
stroke (6 weeks), the number of SOM and/or NPY express-
ing cell is further increased, exceeding also the baseline 
number. This stroke-related effect appears to occur in the 
ischemia injured striatum, and not because of a reduc-
tion of SOM+ cells in contralateral striatum, as no differ-
ences were detected in cell number between sham brains 
and contralateral hemispheres (Fig. S3). Remarkably, the 
number of these cells increased almost 40% in compari-
son to the heathy hemisphere 6 weeks after stroke indicat-
ing that this is not likely the result of an acute response 
to stroke. Whether the increase of SOM+ and/or NPY+ 
interneurons represents one of the mechanisms behind 
spontaneous neurological recovery after stroke is an attrac-
tive hypothesis to be proved in future studies. Although 
speculative, this could be the case, since the increase of 
SOM+ and/or NPY+ interneurons failed to occur in the 
same T2D mice where we also observed decreased neu-
rological recovery (previously published in the first part 
of this study in Pintana et al. (2019). Indeed, decreased 
capacity to recover from stroke in T2D patients has long 
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been established (Jorgensen et al. 1994; Baird et al. 2002; 
Megherbi et al. 2003) and represents an important clini-
cal problem. Impaired stroke recovery in T2D depends, at 
least in part, on weakened neuroplasticity (Alia et al. 2017; 
Sweetnam et al. 2012; Tulsulkar et al. 2016; Dhungana 
et al. 2013), where interneurons play an important role 
(Calcagnotto 2016; Caillard et al. 2000). The identifica-
tion of neuronal cell populations that could be involved in 
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decreased recovery after stroke is very important in this 
respect and recent works in this field have suggested that 
PV+ interneurons could be involved in these effects (Park 
and Koh 2018; Pintana et al. 2019). Although speculative, 
the results of our study showing an increase of SOM+/
NPY+ interneurons 6 weeks after stroke suggest that these 
cells could also be part of a “neuroplastic response” after 
stroke that is important for spontaneous stroke recovery 
and that could be hampered by T2D. This response could 
not be appreciated by counting SOM+/NPY+ in the whole 
striatum since the effect of T2D was specifically affecting 
the infarct but not the peri-infarct area. Although specula-
tive, this observation of possible T2D-induced alteration 
of neuroplasticity involving SOM+/NPY+ interneurons 
could also open up for the possibility of developing new, 
targeted therapies to counteract negative effects of T2D on 
SOM+/NPY+ interneurons and facilitate stroke recovery.
Although no differences were found in average infarct 
volume between SD- and HFD-fed mice, as we demon-
strated in these same mice in the first part of this study (Pin-
tana et al. 2019), peri-infarct and infarct areas are variable 
between all mice, and this factor can affect the evaluation 
of raw or normalized cell number quantifications. Thereby 
a reasonable way to fairly compare cell number between 
animals was to calculate cell density (cell number divided 
by the area of infarct or peri-infarct area as described in 
“Materials and Methods” section). We then encountered 
two additional problems: (1) the tissue deformation 6 weeks 
after stroke (Ding et al. 2010; Li et al. 2014) and (2) the 
heterogeneous distribution of SOM+ cells in the striatum 
(Fig. 1). When it comes to the tissue deformation, literature 
clearly shows that after stroke the volume of infarct core var-
ies considerably during time: in the first hours after stroke, 
an edema occurs, contributing to the swelling of infarct tis-
sue that peaks at 1–2 days after surgery (Li et al. 2014). 
From this time point, the edema starts to regress and after 
1–2 weeks the removal of dead tissue by macrophages and 
microglia results in the infarct area being gradually replaced 
by a scar tissue that leads to a reduction of the infarct volume 
(Macrae 2011). This time-dependent volume change (swell-
ing/shrinking) after stroke, leads to the necessity to find cor-
rections for morphological evaluations of stroke outcome; 
as an example, infarct volume can be assessed indirectly 
as the volume of the undamaged portion of the ipsilateral 
hemisphere subtracted from the volume of contralateral 
hemisphere and this method is based on the assumption that 
tissue volume changes almost exclusively within the infarct 
core (Macrae 2011). Concerning the evaluation of cell num-
ber in the infarct core (and comparison to contralateral hemi-
sphere), one of the used techniques to overcome the problem 
of volume variations is to identify a region of interest (ROI) 
in the stroke affected area, and to select the symmetrical 
adjusted area in the contralateral hemisphere (Khodanovich 
et al. 2018). The evaluation of cell number/density in a 
small portion of infarct core (such as a selected ROI) could 
mask the variation of tissue swelling/shrinking, but, in case 
of not uniformly distributed cells as SOM+ interneurons, 
could also give a partial or even false result. Moreover, at 
longer time points (> 14 days) the deformation (shrinking) 
effect could be too evident to be masked by the isolation of 
a small ROI. Thereby, there is the need to find new meth-
ods to evaluate cell density in the striatum-damaged area 
discriminating between peri-infarct and infarct areas. From 
our previous data, we confirmed that only the infarct area 
is affected by tissue deformation, while the peri-infarct not-
affected striatum does not change its volume during time 
(Fig. S2). The difference in the volume variation between the 
two areas is further endorsed by the universally accepted and 
above discussed method for infarct volume evaluation that 
assumes that the "not affected" brain area does not change its 
volume during time. As already discussed, this differential 
deformation of striatum must be taken in consideration in 
cell density quantifications, as a reduction of the area used to 
calculate cell density (that occurs only in infarct area) would 
create an artifact in the obtained values. This issue was over-
come by adjusting cell density obtained to a deformation 
coefficient (αs), that represent the magnitude of infarct tissue 
deformation (shrinking in this case) for every single mouse. 
As the peri-infarct area is not affected by deformation (Fig. 
S2), the αs obtained would have been equal to 1, and thus 
cell density in peri-infarct area did not need to be adjusted.
When it comes to the non-homogeneous distribution of 
SOM+ cell in the striatum, if cell density is evaluated by dis-
criminating between different areas of the striatum, even the 
smallest difference in cell distribution should affect the reli-
ability of the obtained results. As striatal SOM+ cells con-
centrate mainly nearby the lateral ventricle, that is the area 
usually less affected in focal stroke models, comparing the 
Fig. 3  Effects of T2D on Type 2 diabetes (T2D) on stroke-induced 
Somatostatin (SOM)+ cells density (δc) increase 6  weeks after 
stroke discriminating between peri-infarct and infarct area. Repre-
sentation of the areas in which striatum was divided for cell density 
analysis (δc) (a). SOM+ cell density (δc) in peri-infarct area in ipsi-
lateral striatum compared to contralateral peri-infarct corresponding 
area in Standard Diet (SD) fed mice 6 weeks after stroke (b). SOM+ 
cell density (δc) in infarct area in ipsilateral striatum compared to 
contralateral infarct corresponding area (adjusted for infarct volume 
shrinking) in SD-fed mice 6 weeks after stroke (c). SOM+ cell den-
sity (δc) in peri-infarct area in ipsilateral striatum compared to con-
tralateral peri-infarct corresponding area in High Fat Diet (HFD) fed 
mice 6 weeks after stroke (d). SOM+ cell density (δc) in infarct area 
in ipsilateral striatum compared to contralateral infarct corresponding 
area (adjusted for infarct volume shrinking) in HFD-fed mice 6 weeks 
after stroke (e). Stroke-induced SOM+ cell increase in peri-infarct 
and infarct areas in ipsilateral striatum compared to contralateral cor-
responding area (dotted line) in SD and HFD-fed mice 6 weeks after 
stroke (f). Unpaired t test with Welch’s correction, means ± SEM 
*P < 0.05
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density of SOM+ cells in ipsilateral peri-infarct area to the 
density of the whole contralateral striatum, would result in 
a false increase of SOM+ cells. The striatal area nearby the 
lateral ventricle is, indeed, enriched of SOM+ cells in com-
parison to the whole striatum, even in physiological condi-
tions. Thus, to obtain reliable results, peri-infarct and infarct 
cell density in ipsilateral striatum should be compared to the 
same corresponding area in the contralateral hemisphere. To 
identify accurately the corresponding peri-infarct and infarct 
areas in the contralateral hemisphere, we took advantage of 
a digital image software (Adobe Photoshop CC 2019, see 
“Materials and Methods” section for details).
In summary, the use the new method gave us the oppor-
tunity to evaluate SOM+ cell density in a precise and repro-
ducible way, discriminating between peri-infarct and infarct 
areas and, in this way, to unmask an effect of T2D on SOM+ 
cells in the ischemic core that was otherwise undetectable 
by analyzing the whole striatum.
The last objective of this study was to understand the 
origin of these "new" detected SOM+ cells 6 weeks after 
stroke. For this reason, several co-immunostaining exper-
iments with SOM were performed. First, we wanted to 
confirm the neuronal nature of these cells. From our data, 
100% of SOM+ cells co-stained with NeuN, a marker 
of adult neurons, confirming that they are neurons. No 
co-staining was found between SOM and spiny neurons 
(detected by DARP 32) or other interneuron populations 
(PV+, Cr+, ChAT+) suggesting the unlikely stroke-
induced expression of SOM in other neuronal population. 
No co-staining was detected between SOM and BrdU 
either, indicating that the increase of SOM+ cell number 
is not related to new-born cells/neurogenesis. However, as 
BrdU was injected only in the first 2 weeks after stroke, 
we cannot rule out (although unlikely) that the recorded 
increase of SOM+ cells at 6 weeks after stroke could be 
the result of a late (occurring after 2 weeks) neurogen-
esis process. Finally, we ruled out the potential expres-
sion of SOM in microglia, astroglia and oligodendrocytes. 
Based on these results, we speculate that the increase of 
SOM+/NPY+ neurons 6 weeks after stroke is the result 
of increased expression of these peptides in SOM+/NPY+ 
interneurons that, in normal uninjured conditions, do not 
produce levels of SOM or NPY detectable with stand-
ard immunohistological methods. However, to prove this 
hypothesis, the stroke-induced changes in expression of 
Fig. 4  Characterization of SOM+ cells. Representative images from 
ipsilateral striatum of SOM+ cells co-staining with NeuN (a), Oligo-
dendrocyte transcription factor (Olig-2) (b), Ionized calcium-binding 
adaptor molecule 1 (Iba-1) (c), Glial fibrillary acidic protein (GFAP) 
(d), S100Beta (e); dopamine- and cAMP-regulated neuronal phos-
phoprotein-32 (DARPP-32) (f), parvalbumin (PV) (g), Calretinin (Cr) 
(h), choline acetyltransferase (ChAT) (i), bromodeoxyuridine (BrdU) 
(j), at 6 weeks after stroke
▸
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these peptides will need verification using more suitable 
methods, such as western blot analyses or rt-PCR. Unfor-
tunately, in this study the brains were PFA-fixed, which 
prevented us from conducing such analyses, lack of which 
is a weakness of this study.
In conclusion we show that stroke increases the num-
ber of SOM+/NPY+ interneurons in the whole striatum 
during the recovery phase, likely in interneurons express-
ing SOM and/or NPY under undetectable levels in the 
uninjured brain. T2D completely abolished this effect 
in the ischemic core. The physiological meaning of this 
regulation is to date unknown but should be investigated 
by future studies aimed at identifying cellular targets to 
improve stroke recovery. We also show the development 
of a cellular counting system that allows precise, reliable 
and reproducible quantifications of potentially any cel-
lular type in the stroke-damaged brain allowing to dis-
criminate between infarct core and peri-infarct area and 
that takes in consideration tissue deformation and the not 
uniform distribution of cells in the considered brain area. 
The application of this method is simple and should bear 
great potential to quantify virtually any type of cells in the 
stroke damaged brain.
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